Times Square Capital Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Times Square Capital Management, LLC

  • $6.49 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022
BUY
$79.4 - $116.36 $5.83 Million - $8.54 Million
73,400 Added 10.62%
764,800 $61 Million
Q1 2022

May 06, 2022
BUY
$86.42 - $109.81 $17.9 Million - $22.8 Million
207,500 Added 42.88%
691,400 $72.7 Million
Q4 2021

Feb 04, 2022
BUY
$98.56 - $119.91 $11.2 Million - $13.6 Million
113,800 Added 30.75%
483,900 $52.1 Million
Q3 2021

Nov 08, 2021
BUY
$91.91 - $110.37 $34 Million - $40.8 Million
370,100 New
370,100 $40.5 Million

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Times Square Capital Management, LLC Portfolio

Follow Times Square Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email